OrthoPediatrics Statistics
Total Valuation
OrthoPediatrics has a market cap or net worth of $513.44 million. The enterprise value is $576.83 million.
| Market Cap | 513.44M |
| Enterprise Value | 576.83M |
Important Dates
The next confirmed earnings date is Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OrthoPediatrics has 25.68 million shares outstanding. The number of shares has increased by 1.69% in one year.
| Current Share Class | 25.68M |
| Shares Outstanding | 25.68M |
| Shares Change (YoY) | +1.69% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 6.63% |
| Owned by Institutions (%) | 64.36% |
| Float | 17.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.11 |
| Forward PS | 1.89 |
| PB Ratio | 1.51 |
| P/TBV Ratio | 3.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.33.
| Current Ratio | 5.21 |
| Quick Ratio | 2.19 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.25 |
Financial Efficiency
Return on equity (ROE) is -11.57% and return on invested capital (ROIC) is -3.76%.
| Return on Equity (ROE) | -11.57% |
| Return on Assets (ROA) | -3.39% |
| Return on Invested Capital (ROIC) | -3.76% |
| Return on Capital Employed (ROCE) | -8.04% |
| Weighted Average Cost of Capital (WACC) | 8.83% |
| Revenue Per Employee | $404,151 |
| Profits Per Employee | -$65,907 |
| Employee Count | 602 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 0.52 |
Taxes
In the past 12 months, OrthoPediatrics has paid $93,000 in taxes.
| Income Tax | 93,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.72% in the last 52 weeks. The beta is 0.99, so OrthoPediatrics's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -10.72% |
| 50-Day Moving Average | 18.86 |
| 200-Day Moving Average | 17.66 |
| Relative Strength Index (RSI) | 55.38 |
| Average Volume (20 Days) | 145,569 |
Short Selling Information
The latest short interest is 881,263, so 3.43% of the outstanding shares have been sold short.
| Short Interest | 881,263 |
| Short Previous Month | 895,491 |
| Short % of Shares Out | 3.43% |
| Short % of Float | 5.16% |
| Short Ratio (days to cover) | 5.35 |
Income Statement
In the last 12 months, OrthoPediatrics had revenue of $243.30 million and -$39.68 million in losses. Loss per share was -$1.68.
| Revenue | 243.30M |
| Gross Profit | 177.79M |
| Operating Income | -26.39M |
| Pretax Income | -39.58M |
| Net Income | -39.68M |
| EBITDA | -14.80M |
| EBIT | -36.59M |
| Loss Per Share | -$1.68 |
Balance Sheet
The company has $48.81 million in cash and $112.20 million in debt, with a net cash position of -$63.39 million or -$2.47 per share.
| Cash & Cash Equivalents | 48.81M |
| Total Debt | 112.20M |
| Net Cash | -63.39M |
| Net Cash Per Share | -$2.47 |
| Equity (Book Value) | 338.71M |
| Book Value Per Share | 13.23 |
| Working Capital | 198.68M |
Cash Flow
In the last 12 months, operating cash flow was -$3.98 million and capital expenditures -$8.64 million, giving a free cash flow of -$12.63 million.
| Operating Cash Flow | -3.98M |
| Capital Expenditures | -8.64M |
| Depreciation & Amortization | 21.79M |
| Net Borrowing | 23.49M |
| Free Cash Flow | -12.63M |
| FCF Per Share | -$0.49 |
Margins
Gross margin is 73.07%, with operating and profit margins of -10.85% and -16.31%.
| Gross Margin | 73.07% |
| Operating Margin | -10.85% |
| Pretax Margin | -16.27% |
| Profit Margin | -16.31% |
| EBITDA Margin | -6.08% |
| EBIT Margin | -15.04% |
| FCF Margin | n/a |
Dividends & Yields
OrthoPediatrics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.69% |
| Shareholder Yield | -1.69% |
| Earnings Yield | -7.73% |
| FCF Yield | -2.46% |
Analyst Forecast
The average price target for OrthoPediatrics is $25.00, which is 25.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $25.00 |
| Price Target Difference | 25.06% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 11.82% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrthoPediatrics has an Altman Z-Score of 1.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.76 |
| Piotroski F-Score | 3 |